Mason Morfit ValueAct Holdings
Mason Morfit is chief executive officer of ValueAct Capital, a major constructive-activist investment firm. ValueAct typically takes significant stakes in companies and works with boards on strategy, capital allocation, and operational improvement. Morfit’s campaigns and holdings are closely watched in both activist and fundamental investing communities.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$336M |
| 2 |
Morgan Stanley
MS
|
+$236M |
| 3 |
Arcosa
ACA
|
+$196M |
| 4 |
Seagate
STX
|
+$37.8M |
| 5 |
KKR & Co
KKR
|
+$22.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Armstrong World Industries
AWI
|
+$190M |
| 2 |
Trinity Industries
TRN
|
+$181M |
| 3 |
Bread Financial
BFH
|
+$172M |
| 4 |
Dentsply Sirona
XRAY
|
+$83M |
| 5 |
Gen Digital
GEN
|
+$10.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 59.58% |
| 2 | Technology | 13.12% |
| 3 | Industrials | 10.13% |
| 4 | Real Estate | 9.93% |
| 5 | Healthcare | 4.15% |
Similar funds
Mason Morfit's Q4 2018 Portfolio in Review
As of Q4 2018, Mason Morfit held 23 positions worth $8.03B, down 21% from $10.2B the previous quarter. Its ten largest holdings account for 95% of the portfolio.
Mason Morfit deployed $256M of net new capital in Q4 2018, opening 4 new positions and adding to 11 existing holdings. Its largest new stake was Arcosa: 7,135,963 shares worth $198M.
By sector, the portfolio is most concentrated in Financials at 60% of assets, down from 60% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Armstrong World Industries, an estimated $190M trimmed.
- Mason Morfit's largest Q4 2018 buy was Arcosa: 7,135,963 shares worth $198M.
- Mason Morfit added most to Citigroup in Q4 2018, an estimated $336M increase.
- Mason Morfit's biggest Q4 2018 reduction was Armstrong World Industries, cutting an estimated $190M.
- Mason Morfit fully exited Dentsply Sirona in Q4 2018, selling an estimated $83M.
- Mason Morfit's ten largest holdings make up 95% of its $8.03B portfolio in Q4 2018.
- Mason Morfit opened 4 new positions and closed 2 in Q4 2018.
- Mason Morfit's portfolio value fell 21% quarter-over-quarter to $8.03B.
Based on ValueAct Holdings's 13F filing for Q4 2018, filed 14 Feb 2019.